Osteopontin and fibronectin levels are decreased in vitreous of autoimmune uveitis and retinal expression of both proteins indicates ECM Re-modeling

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Deeg, Cornelia A ^a   Eberhardt, Christina ^a   Hofmaier, Florian ^a   Amann, Barbara ^a   Hauck, Stefanie M ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; OSTEOPONTIN; VIMENTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL ADHESION; CELL FUNCTION; CELL LOSS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; HORSE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MUELLER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECURRENT DISEASE; UPREGULATION; UVEITIS; VITREOUS BODY; WESTERN BLOTTING; ANIMAL; CELL CULTURE; HUMAN; METABOLISM; PATHOLOGY; RETINA;

ANIMALS; AUTOIMMUNE DISEASES; CELLS, CULTURED; DOWN-REGULATION; EXTRACELLULAR MATRIX; FIBRONECTINS; HORSES; HUMANS; IMMUNOHISTOCHEMISTRY; OSTEOPONTIN; RECURRENCE; RETINA; UP-REGULATION; UVEITIS; VIMENTIN; VITREOUS BODY;

EID: 83355168794     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027674     Document Type: Article

References (56)

1. Caspi RR, (2010) A look at autoimmunity and inflammation in the eye. J Clin Invest 120: 3073-3083.
2. Nussenblatt RB, (1990) The natural history of uveitis. Int Ophthalmol 14: 303-308.
3. Hauck SM, Dietter J, Kramer RL, Hofmaier F, Zipplies JK, et al. (2010) Deciphering membrane-associated molecular processes in target tissue of autoimmune uveitis by label-free quantitative mass spectrometry. Mol Cell Proteomics 9: 2292-2305.
4. Caspi RR, (2011) Understanding autoimmune uveitis through animal models. The Friedenwald Lecture. Invest Ophthalmol Vis Sci 52: 1872-1879.
5. Deeg CA, Ehrenhofer M, Thurau SR, Reese S, Wildner G, et al. (2002) Immunopathology of recurrent uveitis in spontaneously diseased horses. Exp Eye Res 75: 127-133.
6. Deeg CA, Hauck SM, Amann B, Pompetzki D, Altmann F, et al. (2008) Equine recurrent uveitis-a spontaneous horse model of uveitis. Ophthalmic Res 40: 151-153.
7. Deeg CA, (2009) A proteomic approach for studying the pathogenesis of spontaneous equine recurrent uveitis (ERU). Vet Immunol Immunopathol 128: 132-136.
8. Deeg CA, Kaspers B, Gerhards H, Thurau SR, Wollanke B, et al. (2001) Immune responses to retinal autoantigens and peptides in equine recurrent uveitis. Invest Ophthalmol Vis Sci 42: 393-398.
9. Deeg CA, Pompetzki D, Raith AJ, Hauck SM, Amann B, et al. (2006) Identification and functional validation of novel autoantigens in equine uveitis. Mol Cell Proteomics 5: 1462-1470.
10. Deeg CA, Raith AJ, Amann B, Crabb JW, Thurau SR, et al. (2007) CRALBP is a highly prevalent autoantigen for human autoimmune uveitis. Clin Dev Immunol 2007: 39245.
11. Deeg CA, Hauck SM, Amann B, Kremmer E, Stangassinger M, et al. (2007) Major retinal autoantigens remain stably expressed during all stages of spontaneous uveitis. Mol Immunol 44: 3291-3296.
12. Dunkle ET, Zaucke F, Clegg DO, (2007) Thrombospondin-4 and matrix three-dimensionality in axon outgrowth and adhesion in the developing retina. Exp Eye Res 84: 707-717.
13. Frantz C, Stewart KM, Weaver VM, (2010) The extracellular matrix at a glance. J Cell Sci 123: 4195-4200.
14. Sorokin L, (2010) The impact of the extracellular matrix on inflammation. Nat Rev Immunol 10: 712-723.
15. Hynes RO, (2009) The extracellular matrix: not just pretty fibrils. Science 326: 1216-1219.
16. Adams JC, Watt FM, (1993) Regulation of development and differentiation by the extracellular matrix. Development 117: 1183-1198.
17. Kim SH, Turnbull J, Guimond S, (2011) Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol 209: 139-151.
18. Pankov R, Yamada KM, (2002) Fibronectin at a glance. J Cell Sci 115: 3861-3863.
19. Wang XL, Yu T, Zhang JS, Yan QC, Luo YH, (2009) Fibronectin and focal adhesion kinase small interfering RNA modulate rat retinal Muller cells adhesion and migration. Cell Mol Neurobiol 29: 549-556.
20. Eberhardt C, Amann B, Feuchtinger A, Hauck SM, Deeg CA, (2011) Differential expression of inwardly rectifying K(+) channels and aquaporins 4 and 5 in autoimmune uveitis indicates misbalance in Muller glial cell-dependent ion and water homeostasis. Glia 59: 697-707.
21. Meller R, Stevens SL, Minami M, Cameron JA, King S, et al. (2005) Neuroprotection by osteopontin in stroke. J Cereb Blood Flow Metab 25: 217-225.
22. Del Rio P, Irmler M, Arango-Gonzalez B, Favor J, Bobe C, et al. (2011) GDNF-induced osteopontin from Muller glial cells promotes photoreceptor survival in the Pde6brd1 mouse model of retinal degeneration. Glia 59: 821-832.
23. Kitamura M, Iwabuchi K, Kitaichi N, Kon S, Kitamei H, et al. (2007) Osteopontin aggravates experimental autoimmune uveoretinitis in mice. J Immunol 178: 6567-6572.
24. Iwata D, Kitamura M, Kitaichi N, Saito Y, Kon S, et al. (2010) Prevention of experimental autoimmune uveoretinitis by blockade of osteopontin with small interfering RNA. Exp Eye Res 90: 41-48.
25. Ehrenhofer MC, Deeg CA, Reese S, Liebich HG, Stangassinger M, et al. (2002) Normal structure and age-related changes of the equine retina. Vet Ophthalmol 5: 39-47.
26. Eberhardt C, Amann B, Stangassinger M, Hauck SM, Deeg CA, (2011) Isolation, characterization and establishment of an equine retinal glial cell line: a prerequisite to investigate the physiological function of Muller cells in the retina. J Anim Physiol Anim Nutr (Berl) doi:10.1111/j.1439-0396.2011.01147.x. [Epub ahead of print].
27. Hikita ST, Vistica BP, Jones HR, Keswani JR, Watson MM, et al. (2006) Osteopontin is proinflammatory in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 47: 4435-4443.
28. Hauck SM, Schoeffmann S, Amann B, Stangassinger M, Gerhards H, et al. (2007) Retinal Mueller glial cells trigger the hallmark inflammatory process in autoimmune uveitis. J Proteome Res 6: 2121-2131.
29. Deeg CA, Altmann F, Hauck SM, Schoeffmann S, Amann B, et al. (2007) Down-regulation of pigment epithelium-derived factor in uveitic lesion associates with focal vascular endothelial growth factor expression and breakdown of the blood-retinal barrier. Proteomics 7: 1540-1548.
30. Zipplies JK, Hauck SM, Schoeffmann S, Amann B, Stangassinger M, et al. (2009) Serum PEDF levels are decreased in a spontaneous animal model for human autoimmune uveitis. J Proteome Res 8: 992-998.
31. Hofmaier F, Hauck SM, Amann B, Degroote RL, Deeg CA, (2011) Changes in matrix metalloproteinase network in spontaneous autoimmune uveitis model. Invest Ophthalmol Vis Sci 52: 2314-2320.
32. Geiger B, Bershadsky A, Pankov R, Yamada KM, (2001) Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2: 793-805.
33. Hiscott P, Waller HA, Grierson I, Butler MG, Scott D, (1992) Local production of fibronectin by ectopic human retinal cells. Cell Tissue Res 267: 185-192.
34. Ljubimov AV, Burgeson RE, Butkowski RJ, Couchman JR, Zardi L, et al. (1996) Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem 44: 1469-1479.
35. Kohno T, Sorgente N, Ishibashi T, Goodnight R, Ryan SJ, (1987) Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci 28: 506-514.
36. Chen W, Mo W, Sun K, Huang X, Zhang YL, et al. (2009) Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy. Curr Eye Res 34: 1057-1064.
37. Seiler MJ, Aramant RB, Bergstrom A, (1995) Co-transplantation of embryonic retina and retinal pigment epithelial cells to rabbit retina. Curr Eye Res 14: 199-207.
38. Uga S, Smelser GK, (1973) Electron microscopic study of the development of retinal Mullerian cells. Invest Ophthalmol 12: 295-307.
39. Newman E, Reichenbach A, (1996) The Muller cell: a functional element of the retina. Trends Neurosci 19: 307-312.
40. Franze K, Grosche J, Skatchkov SN, Schinkinger S, Foja C, et al. (2007) Muller cells are living optical fibers in the vertebrate retina. Proc Natl Acad Sci U S A 104: 8287-8292.
41. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A, (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80: 332-336.
42. Garcia M, Vecino E, (2003) Role of Muller glia in neuroprotection and regeneration in the retina. Histol Histopathol 18: 1205-1218.
43. Chowdhury UR, Jea SY, Oh DJ, Rhee DJ, Fautsch MP, (2011) Expression Profile of the Matricellular Protein Osteopontin in Primary Open-Angle Glaucoma and the Normal Human Eye. Invest Ophthalmol Vis Sci.
44. Kase S, Yokoi M, Saito W, Furudate N, Ohgami K, et al. (2007) Increased osteopontin levels in the vitreous of patients with diabetic retinopathy. Ophthalmic Res 39: 143-147.
45. Uede T, (2011) Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol Int 61: 265-280.
46. Sodek J, Ganss B, McKee MD, (2000) Osteopontin. Crit Rev Oral Biol Med 11: 279-303.
47. Kunii Y, Niwa S, Hagiwara Y, Maeda M, Seitoh T, et al. (2009) The immunohistochemical expression profile of osteopontin in normal human tissues using two site-specific antibodies reveals a wide distribution of positive cells and extensive expression in the central and peripheral nervous systems. Med Mol Morphol 42: 155-161.
48. Chidlow G, Wood JP, Manavis J, Osborne NN, Casson RJ, (2008) Expression of osteopontin in the rat retina: effects of excitotoxic and ischemic injuries. Invest Ophthalmol Vis Sci 49: 762-771.
49. Roehlecke C, Schaller A, Knels L, Funk RH, (2009) The influence of sublethal blue light exposure on human RPE cells. Mol Vis 15: 1929-1938.
50. Sugitani H, Wachi H, Murata H, Sato F, Mecham RP, et al. (2003) Characterization of an in vitro model of calcification in retinal pigmented epithelial cells. J Atheroscler Thromb 10: 48-56.
51. Bringmann A, Iandiev I, Pannicke T, Wurm A, Hollborn M, et al. (2009) Cellular signaling and factors involved in Muller cell gliosis: neuroprotective and detrimental effects. Prog Retin Eye Res 28: 423-451.
52. Schroeter M, Zickler P, Denhardt DT, Hartung HP, Jander S, (2006) Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice. Brain 129: 1426-1437.
53. Chen W, Ma Q, Suzuki H, Hartman R, Tang J, et al. (2011) Osteopontin reduced hypoxia-ischemia neonatal brain injury by suppression of apoptosis in a rat pup model. Stroke 42: 764-769.
54. Tezel TH, Del Priore LV, Kaplan HJ, (2004) Reengineering of aged Bruch's membrane to enhance retinal pigment epithelium repopulation. Invest Ophthalmol Vis Sci 45: 3337-3348.
55. Ho TC, Del Priore LV, (1997) Reattachment of cultured human retinal pigment epithelium to extracellular matrix and human Bruch's membrane. Invest Ophthalmol Vis Sci 38: 1110-1118.
56. Stocks SZ, Shiels IA, Taylor SM, (1999) Homologous serum-stimulated fibronectin synthesis in human retinal pigmented epithelial cells. Aust N Z J Ophthalmol 27: 247-249.